Relevant bibliographies by topics / Modified vaccinia Ankara / Dissertations / Theses
To see the other types of publications on this topic, follow the link: Modified vaccinia Ankara.

Dissertations / Theses on the topic 'Modified vaccinia Ankara'

Author: Grafiati
Published: 4 June 2021
Last updated: 26 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 26 dissertations / theses for your research on the topic 'Modified vaccinia Ankara.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Price, Philip John Ritchie. "Leukocyte trafficking during infection with modified vaccinia virus Ankara." Diss., Ludwig-Maximilians-Universität München, 2014. http://nbn-resolving.de/urn:nbn:de:bvb:19-173737.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Meiser, Andrea. "Presentation of Recombinant Proteins in Modified Vaccinia Virus Ankara Extracellular Enveloped Virions." Diss., lmu, 2003. http://nbn-resolving.de/urn:nbn:de:bvb:19-10247.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Alharbi, Naif K. "New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector." Thesis, University of Oxford, 2014. http://ora.ox.ac.uk/objects/uuid:bbde86fd-ea8f-4e66-b260-f923d7e01e4b.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Sakwa, Imme [Verfasser]. "Characterization of orthopox ankyrin repeat proteins in the modified vaccinia virus Ankara background / Imme Sakwa." Berlin : Freie Universität Berlin, 2014. http://d-nb.info/1048327418/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kutscher, Sarah. "Immunomonitoring technologies for the evaluation of Modified Vaccinia Virus Ankara expressing HIV-1 nef as a vaccine against AIDS." Diss., lmu, 2010. http://nbn-resolving.de/urn:nbn:de:bvb:19-117303.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rodriguez, Pozo Andre. "Deep characterization of the Modified Vaccinia Ankara vaccine induced B cell response in the context of prime-boost immunization." Thesis, Université Paris-Saclay (ComUE), 2019. http://www.theses.fr/2019SACLS061.

Full text
Abstract:
Les anticorps sont des corrélats de protection pour différents vaccins qui sont sur le marché. Une meilleure connaissance des modes d’action des vaccins au cours de la primo-vaccination et des rappels sont nécessaires pour améliorer ceux déjà disponibles et ceux en cours de développement.En développant un pipeline d’analyse des données de cytométrie en masse, nous avons étudié l’hétérogénéité des cellules B de macaques et établi un atlas des cellules B dans diffèrent organes.Nous avons démontré que les cellules B du sang sont enrichies au cours du temps après la primo vaccination et/ou le rapp
APA, Harvard, Vancouver, ISO, and other styles
7

Johnen, Heiko. "Vergleich von rekombinanten Vaccinia- und DNA-Vektoren zur Tumorimmuntherapie im C57BL/6-Mausmodell." Phd thesis, [S.l.] : [s.n.], 2002. http://pub.ub.uni-potsdam.de/2002/0028/johnen.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Song, Fei. "Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens." Diss., Ludwig-Maximilians-Universität München, 2014. http://nbn-resolving.de/urn:nbn:de:bvb:19-172469.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Veit, Svenja [Verfasser], and Gerd [Akademischer Betreuer] Sutter. "Characterization of recombinant Modified Vaccinia virus Ankara expressing the Middle East respiratory syndrome coronavirus nucleocapsid protein / Svenja Veit ; Betreuer: Gerd Sutter." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2019. http://d-nb.info/1193423376/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Marr, Lisa [Verfasser], and Gerd [Akademischer Betreuer] Sutter. "Improving the cellular immunogenicity of recombinant Modified Vaccinia virus Ankara using green fluorescent protein as model system / Lisa Marr. Betreuer: Gerd Sutter." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2016. http://d-nb.info/1110749333/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Link, Ellen Kathrin [Verfasser], and Gerd [Akademischer Betreuer] Sutter. "Characterization of a recombinant Modified Vaccinia Virus Ankara encoding a novel synthetic immunogen of human cytomegalovirus / Ellen Kathrin Link ; Betreuer: Gerd Sutter." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2016. http://d-nb.info/1164377272/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Lauer, Katharina. "A multipathogen vaccine for rabies, hepatitis B, Japanese encephalitis and enterovirus 71." Thesis, University of Manchester, 2016. https://www.research.manchester.ac.uk/portal/en/theses/a-multipathogen-vaccine-for-rabies-hepatitis-b-japanese-encephalitis-and-enterovirus-71(f489f961-317e-4430-becc-0474cae79268).html.

Full text
Abstract:
To enhance the global control of encephalitis and hepatitis caused by rabies virus (RABV), Japanese encephalitis virus (JEV), enterovirus 71 (EV71) and hepatitis B virus (HBV), novel immunisation strategies are needed. All four diseases particularly affect low income countries with marginal health services – an affordable combined vaccine strategy could alleviate the large burden of disease. Therefore, we aimed to construct a multipathogen vaccine assessing the immunising activity of a recombinant modified vaccinia Ankara (MVA), expressing key antigens (RABV-glycoprotein, JEV pre-membrane & en
APA, Harvard, Vancouver, ISO, and other styles
13

Song, Fei [Verfasser], and Gerd [Akademischer Betreuer] Sutter. "Characterization of recombinant Modified Vaccinia virus Ankara for delivery of Middle East Respiratory Syndrome Coronavirus spike protein antigens / Fei Song. Betreuer: Gerd Sutter." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2014. http://d-nb.info/105491477X/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Tscherne, Alina [Verfasser], and Gerd [Akademischer Betreuer] Sutter. "Characterization of a recombinant Modified Vaccinia virus Ankara expressing the severe acute respiratory syndrome virus 2 spike protein / Alina Tscherne ; Betreuer: Gerd Sutter." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2021. http://d-nb.info/1239557264/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Price, Philip John Ritchie [Verfasser], and Gerd [Akademischer Betreuer] Sutter. "Leukocyte trafficking during infection with modified vaccinia virus Ankara : the role of chemokine receptor 1 and complement activation / Philip John Ritchie Price. Betreuer: Gerd Sutter." München : Universitätsbibliothek der Ludwig-Maximilians-Universität, 2014. http://d-nb.info/1058077538/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Deman, Vincent. "Mechanistic insights into vaccine-induced innate immune responses from integrating prior knowledge and experimental data with Boolean models." Electronic Thesis or Diss., université Paris-Saclay, 2025. http://www.theses.fr/2025UPASQ002.

Full text
Abstract:
Les systèmes biologiques, complexes et organisés de façon hiérarchique, relient diverses échelles par des interactions régulatrices robustes régissant leur comportement dynamique et induisant des propriétés émergentes. Des décennies de recherche sur ces systèmes ont généré de vastes connaissances que des travaux plus récents, soutenus par les progrès informatiques, ont cherché à convertir en modèles informatifs. Ceux-ci ont pour but de récapituler des observations expérimentales, d'identifier des mécanismes d'intérêt et de tester in silico des hypothèses pour les optimiser.Parmi les nombreuses
APA, Harvard, Vancouver, ISO, and other styles
17

White, Andrew David. "Immune responses induced by Mycobacterium bovis BCG, and modified vaccinia virus Ankara expressing mycobacterial antigen 85A, when delivered as mucosal or systemic vaccinations to non-human primates." Thesis, Open University, 2016. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.700136.

Full text
Abstract:
Vaccination is the most effective way to control a global disease such as tuberculosis (TB); however, conventional intradermal (ID) injection of the licensed TB vaccine, BCG, provides only limited protection. Mucosal delivery of vaccines to pulmonary surfaces is a loqical approach to generate a protective immune response at the primary site of infection. Non-human primate (NHP) models have been used to compare the safety and immunogenicity of mucosal and ID TB vaccination strategies using BCG and modified vaccinia virus Ankara expressing TB antigen 85A (MVA85A). Mucosal vaccination strategies
APA, Harvard, Vancouver, ISO, and other styles
18

Yi, Zhang [Verfasser], Ingo [Akademischer Betreuer] Drexler, Klaus-Peter [Akademischer Betreuer] Janssen, and Anne [Akademischer Betreuer] Krug. "Characterization of Endogenous Major Histocompatibility Complex Class II Antigen Processing Pathways for Modified Vaccinia Virus Ankara Infection / Zhang Yi. Gutachter: Klaus-Peter Janssen ; Anne Krug. Betreuer: Ingo Drexler." München : Universitätsbibliothek der TU München, 2014. http://d-nb.info/1048677265/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Süzer, Yasemin. "Untersuchung von rekombinantem Vacciniavirus MVA zur Entwicklung von Impfstoffen gegen Infektionen mit Respiratorischen Synzytialviren." Doctoral thesis, Universitätsbibliothek Leipzig, 2008. http://nbn-resolving.de/urn:nbn:de:bsz:15-20080108-072758-1.

Full text
Abstract:
In dieser Arbeit wurden Vektorimpfstoffe auf der Basis rekombinanter Vacciniaviren hinsichtlich ihrer Eignung zur Immunisierung gegen Infektionen mit Respiratorischen Synzytialviren (RSV) untersucht. Hierfür standen genetisches Material und Viruspräparationen des Respiratorischen Synzytialvirus des Rindes (BRSV, Stamm Odijk) sowie des Respiratorischen Synzytialvirus des Menschen (HRSV, Subtyp A2) sowie rekombinante Vacciniaviren MVA-HRSV-F bzw. MVA-HRSV-G zur Verfügung. Rekombinante MVA-Viren, welche die Gene der BRSV-Oberflächenproteine G und F (MVA-BRSV-F, MVA-BRSV-G, MVA-BRSV-Gneu), sowie V
APA, Harvard, Vancouver, ISO, and other styles
20

Lohr, Verena [Verfasser], and Udo [Akademischer Betreuer] Reichl. "Characterization of the avian designer cells AGE1.CR and AGE1.CR.plX considering growth, metabolism and production of influenza virus and Modified Vaccinia Virus Ankara (MVA) / Verena Lohr. Betreuer: Udo Reichl." Magdeburg : Universitätsbibliothek, 2014. http://d-nb.info/1065301170/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Yang, Hongbing. "Characterisation of CD8+T cell responses induced by therapeutic vaccination with HIV-1 clade A gag DNA- and recombinant modified vaccinia virus Ankara (MVA)-vectored vaccines in HIV-1 infected individuals recieving highly active antiretroviaral therapy." Thesis, University of Oxford, 2007. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.442987.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Barbieri, A. "PROGRESSI NELLA TECNOLOGIA DEL VETTORE POXVIRALE MVA: 1. PRODUZIONE DI RICOMBINANTI ESPRIMENTI DUE TRANSGENI 2. TRANSATTIVAZIONE DI GENI CELLULARI." Doctoral thesis, Università degli Studi di Milano, 2015. http://hdl.handle.net/2434/251560.

Full text
Abstract:
Il virus Modified Vaccinia Ankara (MVA) è un ceppo fortemente attenuato di Vaccinia Virus ed è da tempo utilizzato in qualità di vettore vaccinale nell’uomo. La totale incapacità di replicare in cellule di mammifero unita agli alti livelli di espressione dei transgeni (TG) veicolati costituiscono i punti di forza di MVA e ne fanno un vettore estremamente sicuro e potente, in grado di indurre una forte risposta immunitaria nei soggetti vaccinati. Uno dei metodi più impiegati per la costruzione di virus MVA ricombinanti (rMVA) sfrutta la ricombinazione omologa tra specifiche regioni del genoma v
APA, Harvard, Vancouver, ISO, and other styles
23

Lantermann, Markus [Verfasser]. "Functional characterization of modified vaccinia virus Ankara-encoded anti-apoptotic proteins / Markus Lantermann." 2009. http://d-nb.info/1000728188/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Meiser, Andrea [Verfasser]. "Presentation of recombinant proteins in modified vaccinia virus Ankara extracellular enveloped virions / vorgelegt von Andrea Meiser." 2002. http://d-nb.info/968880533/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Kutscher, Sarah [Verfasser]. "Immunomonitoring technologies for the evaluation of modified vaccinia virus Ankara expressing HIV-1 nef as a vaccine against AIDS / Sarah Kutscher." 2010. http://d-nb.info/100505942X/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Süzer, Yasemin. "Untersuchung von rekombinantem Vacciniavirus MVA zur Entwicklung von Impfstoffen gegen Infektionen mit Respiratorischen Synzytialviren." Doctoral thesis, 2007. https://ul.qucosa.de/id/qucosa%3A10724.

Full text
Abstract:
In dieser Arbeit wurden Vektorimpfstoffe auf der Basis rekombinanter Vacciniaviren hinsichtlich ihrer Eignung zur Immunisierung gegen Infektionen mit Respiratorischen Synzytialviren (RSV) untersucht. Hierfür standen genetisches Material und Viruspräparationen des Respiratorischen Synzytialvirus des Rindes (BRSV, Stamm Odijk) sowie des Respiratorischen Synzytialvirus des Menschen (HRSV, Subtyp A2) sowie rekombinante Vacciniaviren MVA-HRSV-F bzw. MVA-HRSV-G zur Verfügung. Rekombinante MVA-Viren, welche die Gene der BRSV-Oberflächenproteine G und F (MVA-BRSV-F, MVA-BRSV-G, MVA-BRSV-Gneu), sowie V
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Modified vaccinia Ankara' for other source types:
Journal articles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography